Reckitt Benckiser and Orbis Biosciences have entered into an exclusive cooperation agreement to  develop and commercialize novel technologies in the field of consumer healthcare.  The global license agreement will leverage Orbis’ Precision Particle Fabrication technology. The technology will enable new products for a leading segment of RB’s product portfolio.    “We are proud to be partnering with one of the largest consumer products companies in the world to create dif...